Logo image of GCP

GCP Applied Technologies Inc (GCP) Stock Fundamental Analysis

NYSE:GCP - New York Stock Exchange, Inc. - US36164Y1010 - Common Stock - Currency: USD

32.01  +0.02 (+0.06%)

After market: 32.01 0 (0%)

Fundamental Rating

2

Overall GCP gets a fundamental rating of 2 out of 10. We evaluated GCP against 85 industry peers in the Chemicals industry. GCP may be in some trouble as it scores bad on both profitability and health. GCP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GCP was profitable.
GCP Yearly Net Income VS EBIT VS OCF VS FCFGCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 0.79%
ROE 1.71%
ROIC 4.2%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCP Yearly ROA, ROE, ROICGCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 50 -50 100

1.3 Margins

Industry RankSector Rank
OM 7.24%
PM (TTM) 1.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCP Yearly Profit, Operating, Gross MarginsGCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GCP is destroying value.
The number of shares outstanding for GCP has been increased compared to 1 year ago.
GCP has a better debt/assets ratio than last year.
GCP Yearly Shares OutstandingGCP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
GCP Yearly Total Debt VS Total AssetsGCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.97 indicates that GCP is not in any danger for bankruptcy at the moment.
GCP has a Debt/Equity ratio of 0.54. This is a neutral value indicating GCP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z 3.97
ROIC/WACC0.47
WACC8.96%
GCP Yearly LT Debt VS Equity VS FCFGCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.93 indicates that GCP has no problem at all paying its short term obligations.
GCP has a Quick Ratio of 3.22. This indicates that GCP is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 3.22
GCP Yearly Current Assets VS Current LiabilitesGCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GCP have decreased strongly by -41.86% in the last year.
GCP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.25% yearly.
The Revenue has been growing slightly by 3.34% in the past year.
The Revenue has been decreasing by -1.50% on average over the past years.
EPS 1Y (TTM)-41.86%
EPS 3Y-10.61%
EPS 5Y-22.25%
EPS Q2Q%-31.82%
Revenue 1Y (TTM)3.34%
Revenue growth 3Y-4.83%
Revenue growth 5Y-1.5%
Sales Q2Q%5.92%

3.2 Future

The Earnings Per Share is expected to grow by 4.23% on average over the next years.
GCP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.60% yearly.
EPS Next Y-14.54%
EPS Next 2Y4.29%
EPS Next 3Y4.08%
EPS Next 5Y4.23%
Revenue Next Year6.93%
Revenue Next 2Y4.85%
Revenue Next 3Y4.51%
Revenue Next 5Y4.6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GCP Yearly Revenue VS EstimatesGCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
GCP Yearly EPS VS EstimatesGCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 64.02, the valuation of GCP can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, GCP is valued quite expensively.
Based on the Price/Forward Earnings ratio of 45.28, the valuation of GCP can be described as expensive.
When comparing the Price/Forward Earnings ratio of GCP to the average of the S&P500 Index (22.70), we can say GCP is valued expensively.
Industry RankSector Rank
PE 64.02
Fwd PE 45.28
GCP Price Earnings VS Forward Price EarningsGCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.27
GCP Per share dataGCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.29%
EPS Next 3Y4.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCP Applied Technologies Inc

NYSE:GCP (9/26/2022, 8:04:00 PM)

After market: 32.01 0 (0%)

32.01

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2022-08-05/bmo
Earnings (Next)11-02 2022-11-02/bmo
Inst Owners0.02%
Inst Owner Change0%
Ins Owners3.69%
Ins Owner Change0%
Market Cap2.37B
Analysts46.67
Price Target32.64 (1.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 64.02
Fwd PE 45.28
P/S 2.37
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB N/A
EV/EBITDA 19.27
EPS(TTM)0.5
EY1.56%
EPS(NY)0.71
Fwd EY2.21%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.5
BVpS8.68
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.71%
ROCE N/A
ROIC 4.2%
ROICexc N/A
ROICexgc 5.32%
OM 7.24%
PM (TTM) 1.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.93
Quick Ratio 3.22
Altman-Z 3.97
F-Score5
WACC8.96%
ROIC/WACC0.47
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.86%
EPS 3Y-10.61%
EPS 5Y-22.25%
EPS Q2Q%-31.82%
EPS Next Y-14.54%
EPS Next 2Y4.29%
EPS Next 3Y4.08%
EPS Next 5Y4.23%
Revenue 1Y (TTM)3.34%
Revenue growth 3Y-4.83%
Revenue growth 5Y-1.5%
Sales Q2Q%5.92%
Revenue Next Year6.93%
Revenue Next 2Y4.85%
Revenue Next 3Y4.51%
Revenue Next 5Y4.6%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A